Related Experiment Video
Updated: Feb 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT
Hua Liu1, Haoyu Deng1, Yajie Zhao1
1Nuclear Medicine Department, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
Background:
Thyroid cancer is one of the most prevalent malignancies in endocrine system. Further understanding and revealing the molecular mechanism underlying thyroid cancer are indispensable for the development of effective diagnosis and treatments. In the present study, we attempted to provide novel basis for targeted therapy for thyroid cancer from the aspect of lncRNA-miRNA-mRNA interaction.
Methods:
The expression and cellular function of XIST (X-inactive specific transcript) was determined. miRNAs which may be direct targets of XIST were screened for from online GEO database and miR-34a was selected. Next, the predicted binding between XIST and miR-34a, and the dynamic effect of XIST and miR-34a on downstream MET (hepatocyte growth factor receptor)-PI3K (phosphoinositide 3-kinase)-AKT (α-serine/threonine-protein kinase) signaling was evaluated.
Results:
XIST was significantly up-regulated in thyroid cancer tissues and cell lines; XIST knockdown suppressed the cell proliferation in vivo and the tumor growth in vitro. Based on online database and online tool prediction results, miR-34a was underexpressed in thyroid cancer and might be a direct target of XIST. Herein, we confirmed the negative interaction between XIST and miR-34a; moreover, XIST knockdown could reduce the protein levels of MET, a downstream target of miR-34a, and the phosphorylation of PI3K and AKT. In thyroid cancer tissues, MET mRNA and protein levels of MET were up-regulated; MET was positively correlated with XIST while negatively correlated with miR-34a, further confirming that XIST serves as a ceRNA for miR-34a through sponging miR-34a, competing with MET for miR-34a binding, and finally modulating thyroid cancer cell proliferation and tumor growth.
Conclusion:
In the present study, we provided novel experimental basis for targeted therapy for thyroid cancer from the aspect of lncRNA-miRNA-mRNA interaction.
Insights
Long non-coding RNA XIST is upregulated in thyroid cancer, promoting tumor growth by sponging miR-34a. This interaction impacts the MET-PI3K-AKT pathway, offering a novel target for thyroid cancer therapy.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Thyroid cancer is a prevalent endocrine malignancy.
- Understanding its molecular mechanisms is crucial for effective diagnosis and treatment.
- lncRNA-miRNA-mRNA interactions offer a novel therapeutic avenue.
Purpose of the Study:
- Investigate the role of XIST (X-inactive specific transcript) in thyroid cancer.
- Elucidate the interaction between XIST, miR-34a, and MET signaling.
- Provide a basis for targeted thyroid cancer therapy.
Main Methods:
- Determined XIST expression and function in thyroid cancer.
- Screened for miRNA targets of XIST, identifying miR-34a.
- Evaluated XIST-miR-34a binding and their effect on the MET-PI3K-AKT pathway.
Main Results:
- XIST was upregulated in thyroid cancer tissues and cell lines.
- XIST knockdown inhibited cell proliferation and tumor growth.
- XIST sponged miR-34a, leading to MET upregulation and PI3K/AKT phosphorylation.
- MET positively correlated with XIST and negatively with miR-34a in tissues.
Conclusions:
- XIST acts as a competing endogenous RNA (ceRNA) for miR-34a in thyroid cancer.
- This interaction modulates the MET-PI3K-AKT pathway, affecting tumor growth.
- Findings support XIST as a potential therapeutic target for thyroid cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Cells Coordinate Growth and Proliferation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
What is Cell Signaling?

